Multiple Sclerosis

Patients With MS Testing Positive for COVID-19 Saw Worse Depressive, Anxiety Symptoms

October 29th 2021, 10:33pm


A recent study found patients with multiple sclerosis (MS) experienced depressive and anxiety symptoms during the COVID-19 pandemic prior to vaccine rollout, especially among those who tested positive for COVID-19.

Study: Online Resources Don’t Match Established Physical Activity, Exercise Training Guidelines for MS

October 19th 2021, 5:00pm


A study confirmed that many online resources showed inconsistencies or omissions compared with established guidelines related to physical activity and exercise training, which are known to provide clinical benefits for patients with multiple sclerosis (MS).

Digital Tool Aimed at Detecting MS Progression May Help Providers Facilitate Discussion With Patients

October 13th 2021, 5:45pm


Survey results shows that health care professionals found a digital tool to be useful and useable in facilitating discussions with patients with multiple sclerosis (MS) about whether they are showing signs of disease progression.

Study Finds Some Disease-Modifying Therapies Reduce COVID-19 Protective Immunity in Patients With MS

October 6th 2021, 9:30pm


Some immunosuppressive medications, particularly anti-CD20 monoclonal antibodies, were found to reduce antibodies designed to protect against SARS-CoV-2 infection in patients with multiple sclerosis (MS) who have recovered from COVID-19, investigators concluded.

Education Level May Protect Against Cognitive Decline in MS

September 30th 2021, 12:45pm


Patients with multiple sclerosis (MS) who had a higher education level experienced less cognitive impairment related to their disease than patients with a lower education level, investigators concluded.

Vaccine Myths Detected as Major Reason for Low Vaccination Rates Among Patients With MS

September 23rd 2021, 1:00pm


Misconceptions about the safety and necessity of vaccines were cited as the main reasons for lower-than-recommended vaccination rates among patients with multiple sclerosis (MS), according to new research.

MS Disability, Symptoms Are Worse in Non-White Patients, Study Finds

September 16th 2021, 9:30pm


Non-white patients with multiple sclerosis (MS), particularly African American and Hispanic American patients, were found to experience a higher level of overall disability and more severe symptoms, highlighting current disparities in this disease.

Study: COVID-19 Barriers Halted, Delayed Research on MS Rehabilitation, Quality of Life

September 8th 2021, 8:40pm


In a survey, researchers indicated that the COVID-19 pandemic has placed extra barriers, including a lack of accessibility to patients and competing responsibilities, that have resulted in halts or delays to research on multiple sclerosis (MS) rehabilitation and quality of life.

Study Finds Depression May Increase Mortality Risks in Patients With MS

September 1st 2021, 8:00pm


Patients who have both multiple sclerosis (MS) and depression may have a higher risk of death and vascular disease compared with people who only have 1 or neither of those conditions.

T-Cell Responses Still Detected in Patients With MS Receiving Ocrelizumab and Recovered From COVID-19

August 27th 2021, 7:00pm


Patients with multiple sclerosis (MS) who have recovered from COVID-19 and received the B-cell depleting therapy ocrelizumab for at least 1 year were observed to still have T-cell responses.